Life Sciences Extended protection for medical devices – a hot topic in the UKManufactures of medical devices are requesting an increasing number of patent term extensions in a bid to recover the cost of getting regulatory approval. Recent decisions show that the UK IPO is taking a strict approach when examining patent term extensions for medical devices, but there are still situations where extra protection might be available.Read More 21Aug2014 Patentable parthenotes? Advocate General says yesIn the latest development to the patentability of human stem cells, the AG has recommended that stem cells derived from parthenogenically activated oocytes should not be excluded from patentability any longer. The AG drew the distinction between totipotent and pluripotent cells, noting that cells that do not have the capacity to develop into a human being should not be excluded from patentability.Read More 31Jul2014 UK High Court makes sense of CJEU’s decision on interpretation of Article 3(a)In a pro-patentee judgment, the UK High Court suggests that SPCs can be based on most types of claim provided that the product which is the subject of the SPC falls within the scope of the claim.Read More 29Jul2014 Should High stay, for EPO? Actavis and Pharmacia clash in the High CourtMr Justice Arnold in the Patents Court of the High Court of England and Wales (the ‘Patents Court’) initially refused a request by the patentee, Pharmacia, for a stay of UK revocation proceedings brought by Actavis, pending the outcome of opposition proceedings at the EPO based on three undertakings.Read More 24Jul2014 Changes to searches on applications entering Europe via the PCTAs of 1st November 2014, the EPO is changing the way it searches PCT applications entering the European regional phase which are considered to relate to more than one invention. These changes will result in increased flexibility for the applicant and should help to reduce the likelihood of encountering unexpected costs.Read More 14Jul2014 Patchy report from a gynaecology conference is enough to stop morning after pill patentThe UK’s High Court has decided that Richter Gedeon’s patent for a single dose of the emergency contraceptive levonorgestrel is invalid in view of a report published a few months before the priority date revealing the preliminary results from an incomplete study of the drugRead More 12Jun2014 Clinical trials in the UK are given immunity to patent infringementNew legislation introduced by the UK government should shield clinical trials in the UK from the risk of patent infringement from 1st October 2014.Read More 05Jun2014 Board of Appeal finds Swiss-type claims have different scope to EPC 2000 second medical use claimsA decision (T1780/12) from the EPO technical boards of appeal indicates that Swiss-type claims of the form “Use of [product X] in the manufacture of a medicament for the treatment of [disease Y]” provide a different scope of protection than EPC 2000 second medical use claims of the form “[product X] for use in the treatment of [disease Y]”Read More 29May2014 Genentech’s Herceptin purification patent fails to pass the acid testThe UK’s High Court has decided that Genentech’s patent relating to a composition of Herceptin with reduced acidic variant content is invalidRead More 01May2014 Less is more, but still not enough, for Genentech’s dosing schedule patentThe High Court has decided, in a single judgment, that Genentech’s patents relating to a dosage regimen for Herceptin and a purified composition of non-acidic variants of Herceptin are invalid. This article focuses on the dosage regimen patent.Read More 24Apr2014<1…202122232425> Type Firm News Insights PodcastsServiceProtectDealDisputeUPCSectorHealthcare+Energy+Life SciencesChemistryMaterialsEngineeringTechCreativeArchive2026AugustJulyJuneMayAprilMarchFebruaryJanuary2025DecemberNovemberOctoberSeptemberAugustJulyJuneAprilMarchFebruaryJanuary2024DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2023DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2022DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2021DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2020DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2019DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2018DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2017DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2016DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2015DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2014DecemberNovemberOctoberAugustJulyJuneMayAprilMarchFebruaryJanuary2013DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchJanuary2012NovemberJulyJuneMayAprilFebruaryJanuary
